Cargando…
Immune-Mediated Toxic Epidermal Necrolysis
The treatment of melanoma has advanced over time with the latest modalities being immune checkpoint blockade by programmed death receptor 1 and cytotoxic T-lymphocyte-associated antigen 4 inhibitors. Programmed death receptor 1 inhibitors have been noted to cause multi-system adverse reactions. The...
Autores principales: | Keerty, Dinesh, Koverzhenko, Viktoriya, Belinc, Dalila, LaPorta, Katie, Haynes, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478594/ https://www.ncbi.nlm.nih.gov/pubmed/32923193 http://dx.doi.org/10.7759/cureus.9587 |
Ejemplares similares
-
Toxic Epidermal Necrolysis Secondary to Metronidazole
por: Ali, Junaid, et al.
Publicado: (2021) -
Levofloxacin-Induced Toxic Epidermal Necrolysis
por: Khan, Andeebia A, et al.
Publicado: (2023) -
Phenytoin-Induced Toxic Epidermal Necrolysis
por: Tunuguntla, Mounika Nagarani, et al.
Publicado: (2023) -
Cephalosporin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin
por: Boroda, Konstantin, et al.
Publicado: (2015) -
Recurrent Steven-Johnson/Toxic Epidermal Necrolysis Overlap Syndrome
por: Toledo-Martinez, Juan F, et al.
Publicado: (2022)